| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.10B | 4.69B | 4.60B | 4.35B | 3.78B |
| Gross Profit | 1.56B | 1.27B | 1.18B | 1.40B | 1.13B |
| EBITDA | 1.37B | 1.18B | 1.16B | 1.17B | 913.93M |
| Net Income | 726.18M | 644.30M | 585.09M | 581.95M | 382.78M |
Balance Sheet | |||||
| Total Assets | 9.39B | 8.17B | 8.30B | 7.76B | 7.04B |
| Cash, Cash Equivalents and Short-Term Investments | 720.94M | 601.75M | 630.85M | 483.29M | 578.96M |
| Total Debt | 2.43B | 2.20B | 2.26B | 2.21B | 1.54B |
| Total Liabilities | 3.77B | 3.43B | 3.40B | 3.36B | 2.66B |
| Stockholders Equity | 5.60B | 4.72B | 4.88B | 4.38B | 4.36B |
Cash Flow | |||||
| Free Cash Flow | 276.19M | 534.22M | 570.04M | 71.33M | -635.76M |
| Operating Cash Flow | 1.18B | 1.15B | 1.28B | 782.29M | 401.09M |
| Investing Cash Flow | -988.38M | -690.00M | -772.89M | -1.22B | -1.03B |
| Financing Cash Flow | -95.94M | -467.17M | -359.69M | 379.45M | 579.93M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | HK$10.93B | 5.10 | 13.83% | 1.57% | -13.95% | -13.61% | |
77 Outperform | HK$11.75B | 2.58 | 14.32% | 8.66% | 28.34% | ― | |
73 Outperform | HK$14.53B | 12.66 | 14.15% | 3.23% | 2.87% | 17.03% | |
73 Outperform | HK$10.28B | 2.49 | 7.02% | 2.50% | 11.18% | 46.57% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | HK$4.05B | 11.70 | 17.97% | 2.25% | 14.32% | -19.44% | |
42 Neutral | HK$8.18B | -52.60 | -0.43% | ― | 7.11% | 77.53% |
Impro Precision Industries Limited reported record revenue of HK$5,095.5 million for 2025, up 8.7% year on year, with gross profit rising 10.3% and gross margin edging up to 27.5%. Profit attributable to shareholders hit a record HK$726.2 million, up 12.7%, while adjusted profit rose 12.1%, allowing the board to maintain total dividends at 16.0 HK cents per share, equivalent to a payout ratio of about 44% on adjusted earnings.
Growth was driven by surging demand in medical and artificial intelligence data center–related end-markets, where medical revenue jumped 55.2%, high horsepower engine sales increased 43.3% and diversified industrials related to liquid cooling systems climbed 38.4%. Losses at the ramping Mexico SLP campus, primarily due to high employee turnover and scrap rates, were offset by strong profitability at Chinese plants and lower financing costs, helping underpin a 1.5-fold share price increase during 2025 as global and mainland capital flowed into the stock.
The most recent analyst rating on (HK:1286) stock is a Hold with a HK$7.50 price target. To see the full list of analyst forecasts on Impro Precision Industries Limited stock, see the HK:1286 Stock Forecast page.
Impro Precision Industries Limited has declared a second interim ordinary dividend of HK$0.08 per share for the financial year ending 31 December 2025, reflecting its ongoing policy of returning cash to shareholders. The dividend will be paid in Hong Kong dollars without currency conversion and does not involve any special withholding tax arrangements.
The shares will trade ex‑dividend on 8 April 2026, with the record date set for 14 April 2026 and payment scheduled for 22 April 2026, defining a clear timetable for investors planning around the distribution. The announcement underlines the company’s continued generation of distributable profits and may be seen as a signal of confidence in its operating performance through the 2025 financial year.
The most recent analyst rating on (HK:1286) stock is a Hold with a HK$7.50 price target. To see the full list of analyst forecasts on Impro Precision Industries Limited stock, see the HK:1286 Stock Forecast page.
Impro Precision Industries Limited has announced that its board of directors will convene on 10 March 2026 to review and approve the annual results for the financial year ended 31 December 2025. The board will also consider declaring a second interim dividend for 2025, a decision that could directly affect shareholder returns and signal management’s confidence in the company’s financial performance.
In addition to the results and potential dividend, the board meeting will address any other business matters, underlining a regular governance cycle for the Hong Kong-listed manufacturer. The announcement confirms the current composition of the board, which includes both executive and independent non-executive directors, highlighting the company’s adherence to corporate governance practices expected on the Hong Kong Stock Exchange.
The most recent analyst rating on (HK:1286) stock is a Hold with a HK$7.50 price target. To see the full list of analyst forecasts on Impro Precision Industries Limited stock, see the HK:1286 Stock Forecast page.
Impro Precision Industries Limited has secured shareholder approval at an extraordinary general meeting held on 30 December 2025 to adopt a new share option scheme while terminating its existing scheme, following a poll vote in which approximately 97.9% of the votes cast were in favour. All 1,887,285,665 issued shares were eligible to vote with no restrictions or mandatory abstentions, and the resolution’s strong support, alongside full board attendance, underlines broad shareholder alignment on updating the company’s equity incentive framework, which is likely aimed at enhancing long-term alignment between management, employees and investors.
The most recent analyst rating on (HK:1286) stock is a Buy with a HK$7.49 price target. To see the full list of analyst forecasts on Impro Precision Industries Limited stock, see the HK:1286 Stock Forecast page.